Skip to main content

Table 1 Characteristics of study subjects with post-hemorrhagic hydrocephalus

From: Chemokine and cytokine levels in the lumbar cerebrospinal fluid of preterm infants with post-hemorrhagic hydrocephalus

Subject

ID

Sex

PMA at birth (weeks)

TP (μg/ml)

PMA at CSF sample (weeks)

Temporizing neurosurgical procedure

PMA at temporizing procedure (weeks)

VP shunt surgery PMA (weeks)

1

M

24.00

2369

26.86

RES

27.00

37.57

2

F

29.57

1745

30.29

RES

31.29

36.57

3

F

24.00

6072

26.86

RES

27.86

34.71

4

M

29.00

4564

31.14

RES

31.57

40.86

5

M

26.00

9596

27.43

RES

28.14

38.14

6

M

28.14

2606

28.71

RES

30.14

37.14

7

F

24.57

1270

28.00

RES

30.57

39.29

8

M

24.71

1869

30.57

RES

34.14

59.29

9

M

25.43

1420

27.57

NAa

NA

NA

10

M

25.43

2620

28.71

RES

31.00

53.57

11

M

25.86

1902

27.71

RES

28.14

NAb

12

M

25.29

3735

27.71

RES

28.00

40.00

13

F

29.57

2331

30.00

RES

31.29

36.57

14

F

24.00

4300

26.43

RES

27.00

37.57

  1. PMA post-menstrual age, TP total protein, CSF cerebrospinal fluid, VP ventriculo-peritoneal, RES ventricular reservoir, NA not available
  2. aSubject 9 expired after withdrawal of care by family
  3. bSubject 11 developed a S. capitis RES infection 12 weeks after RES implantation and device tapping for cerebrospinal fluid removal (CSF). CSF samples prior to the 12-week sample were sterile on culture. After infection, the RES was removed and replaced with an external ventricular drain, which was later successfully weaned, and no shunt was implanted. Subject 10 underwent endoscopic third ventriculostomy with choroid plexus cauterization prior to VP shunt placement. Subject 1 had a shunt malfunction within 6 months of VP shunt implantation